4,036 Shares in DocuSign, Inc. (NASDAQ:DOCU) Acquired by Certuity LLC

Certuity LLC bought a new stake in DocuSign, Inc. (NASDAQ:DOCU) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 4,036 shares of the company’s stock, valued at approximately $363,000.

A number of other hedge funds and other institutional investors have also modified their holdings of DOCU. Avior Wealth Management LLC boosted its position in shares of DocuSign by 36.5% during the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock valued at $49,000 after acquiring an additional 145 shares during the last quarter. Linden Thomas Advisory Services LLC raised its stake in DocuSign by 1.1% during the fourth quarter. Linden Thomas Advisory Services LLC now owns 13,540 shares of the company’s stock worth $1,218,000 after purchasing an additional 149 shares during the period. J.W. Cole Advisors Inc. boosted its holdings in DocuSign by 2.0% in the 3rd quarter. J.W. Cole Advisors Inc. now owns 7,946 shares of the company’s stock valued at $493,000 after purchasing an additional 155 shares during the last quarter. Resonant Capital Advisors LLC grew its stake in shares of DocuSign by 0.9% in the 3rd quarter. Resonant Capital Advisors LLC now owns 17,516 shares of the company’s stock valued at $1,088,000 after buying an additional 157 shares during the period. Finally, Optimist Retirement Group LLC increased its holdings in shares of DocuSign by 3.8% during the 3rd quarter. Optimist Retirement Group LLC now owns 4,416 shares of the company’s stock worth $274,000 after buying an additional 161 shares during the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider James P. Shaughnessy sold 7,500 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $90.17, for a total transaction of $676,275.00. Following the sale, the insider now directly owns 43,781 shares in the company, valued at approximately $3,947,732.77. This represents a 14.63 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Peter Solvik sold 10,000 shares of the firm’s stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $91.26, for a total transaction of $912,600.00. Following the completion of the sale, the director now directly owns 150,253 shares in the company, valued at approximately $13,712,088.78. This trade represents a 6.24 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 685,773 shares of company stock worth $66,032,726 in the last ninety days. 1.66% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of research firms recently commented on DOCU. Royal Bank of Canada reiterated a “sector perform” rating and issued a $90.00 price objective (up from $57.00) on shares of DocuSign in a report on Friday, December 6th. Robert W. Baird upped their price target on DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research note on Friday, December 6th. Wells Fargo & Company raised their price objective on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a research report on Friday, December 6th. UBS Group boosted their price objective on shares of DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a report on Friday, December 6th. Finally, Citigroup increased their target price on shares of DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a research note on Friday, December 6th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, DocuSign presently has a consensus rating of “Hold” and an average price target of $92.45.

DocuSign Stock Performance

NASDAQ DOCU opened at $88.29 on Thursday. The firm has a market cap of $17.84 billion, a price-to-earnings ratio of 18.20, a PEG ratio of 7.56 and a beta of 0.89. The firm has a 50 day simple moving average of $92.94 and a 200-day simple moving average of $74.95. DocuSign, Inc. has a one year low of $48.70 and a one year high of $107.86.

DocuSign Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.